The fact that Gpr17 knockout produced positive, but unique, metabolic outcomes in Agrp and Pomc conditional knockout mice supports its potential role as a target for obesity therapy. This evidence concerns the gene POMC and obesity due to melanocortin 4 receptor deficiency.